The Asthma and Allergy Foundation of America (AAFA), as a founding member of the Food Allergy Collaborative, invites you to join us on Aug. 20 to learn about an upcoming patient-focused drug development (PFDD) meeting for food allergy. The purpose of PFDD meetings is to help ensure that patients' experiences, perspectives, needs, and priorities are represented in the drug development process. As new treatment options are developed for food allergy, it is important that the FDA and other key stakeholders – including medical product developers, health care providers, and federal partners – hear directly from patients, their families, caregivers, and patient advocates. This webinar will provide an opportunity to learn more about PFDD meetings and why they are important for the food allergy community. Please join us on Aug. 20, 2021, at 3 p.m. ET to discuss this project and learn how you can get involved. | | |
No comments:
Post a Comment